Rehabilitation in Sleep, Pain, and Bladder Symptoms of NESA Neuromodulation Application in Multiple Sclerosis Patients: A Innovative Treatment
Marina Contreras-Polo1, Raquel Medina-Ramirez2*, Esther Teruel-Hernández3, Martín Vilchez Barrera2, Aníbal Báez-Suárez2 & David Álamo-Arce2
1Clínica Sinapsis Fisioterapia, Illes Balears, Spain
2SocDig Research Group, University of Las Palmas de Gran Canaria, Las Palmas, Spain
3University of Las Palmas de Gran Canaria, Las Palmas, Spain
Dr. Raquel Medina-Ramirez, SocDig Research Group, University of Las Palmas de Gran Canaria, Las Palmas, Spain.
Keywords: Multiple Sclerosis; Overactive Bladder; Pain; Sleep; Neuromodulation
Introduction: Multiple sclerosis is an autoimmune demyelinating inflammatory disease of unknown cause and chronic progression caused by damage to myelin, which impairs the nerves’ ability to conduct electrical impulses. This results in a variety of symptoms including spasticity, fatigue, neuropathic pain and/or urinary incontinence. As they often do not remit and respond poorly to conventional medical treatment, recent attention has focused on novel interventions for bladder, pain and sleep control. Non-invasive superficial neuromodulation using the NESA device can help restore the body’s electrical balance by regulating the autonomic nervous system and is beginning to show promising results in patients with sleep disorders. It may therefore provide an opportunity for an autonomous approach to sleep, bladder, and pain management. The aim of the study was to improve sleep quality, urinary incontinence control and pain perception in patients treated with NESA technology alone.
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).